NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ)
$3.73 0 (0%)
Analysed NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) News Sources
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees
08-12-2025
yahoo.com
Leading Advisory Firms Recommend Voting FOR Lynx1's Independent Nominees
08-12-2025
yahoo.com
Here's Why We're Not At All Concerned With Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation
19-02-2026
yahoo.com
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership
01-07-2026
stocktwits.com
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
23-07-2026
yahoo.com
SMALL-CAP MOVERS: Nasdaq-bound Scancell catches the eye as AIM's headcount falls to 612
24-07-2026
proactiveinvestors.com
Scancell sees high demand in retail share offer, seals £15.7m from UK investors
27-07-2026
proactiveinvestors.com
Scancell confirms advanced talks over reverse merger with Neuphoria
26-06-2026
proactiveinvestors.com
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
26-06-2026
yahoo.com
Neuphoria Therapeutics Agrees to All-Share Takeover by Scancell
23-07-2026
yahoo.com
What is the current price of NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ)?
The current price of NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) is $3.73.
NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) since the previous trading day is $0.
NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ)?
The most recent average sentiment score for NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ)?
The most recent sentiment for NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ) is .
SEC-8K** Filing Available For NEUPHORIA THERAPEUTICS INC (NEUP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.